Last reviewed · How we verify
Betneval ointment - Non-desquamated zone — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Betneval ointment - Non-desquamated zone (Betneval ointment - Non-desquamated zone) — Galderma R&D.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Betneval ointment - Non-desquamated zone TARGET | Betneval ointment - Non-desquamated zone | Galderma R&D | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Betneval ointment - Non-desquamated zone CI watch — RSS
- Betneval ointment - Non-desquamated zone CI watch — Atom
- Betneval ointment - Non-desquamated zone CI watch — JSON
- Betneval ointment - Non-desquamated zone alone — RSS
Cite this brief
Drug Landscape (2026). Betneval ointment - Non-desquamated zone — Competitive Intelligence Brief. https://druglandscape.com/ci/betneval-ointment-non-desquamated-zone. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab